Theralase Technologies Inc. (CVE:TLT – Get Free Report) shares shot up 14.3% on Tuesday . The company traded as high as C$0.28 and last traded at C$0.28. 280,000 shares changed hands during trading, an increase of 143% from the average session volume of 115,417 shares. The stock had previously closed at C$0.25.
Theralase Technologies Stock Up 14.3 %
The stock has a fifty day moving average price of C$0.27 and a two-hundred day moving average price of C$0.23. The company has a market cap of C$68.75 million, a price-to-earnings ratio of -14.00 and a beta of 1.36. The company has a quick ratio of 3.40, a current ratio of 1.21 and a debt-to-equity ratio of 20.58.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
See Also
- Five stocks we like better than Theralase Technologies
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- There Are Different Types of Stock To Invest In
- What Does the Future Hold for Eli Lilly?
- Pros And Cons Of Monthly Dividend Stocks
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
